USA Animal Model Market Reaches USD 976.1 Million in 2023: Projected Growth to USD 1,487.9 Million by 2033

The USA animal model market has achieved a remarkable valuation of approximately USD 976.1 million in 2023, marking a significant milestone in biomedical research and development. A comprehensive study by Future Market Insights underscores the increasing demand for animal models in the USA, which is poised for robust growth with an anticipated Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2033.

The forecasts from this extensive research indicate a surge in demand for animal models, projecting the market to reach an impressive USD 1,487.9 million by 2033. This growth highlights the indispensable role of animal models across various research domains, significantly contributing to scientific advancements and innovative breakthroughs.

Among the species utilized in research, mice have emerged as the dominant choice in the USA market, commanding a substantial share of over 61.03% in 2022. Their genetic proximity to humans and versatility make them invaluable assets in preclinical trials and biomedical studies, leading to their widespread adoption across research laboratories.

As the animal model market continues to expand, its contributions to advancing biomedical research and fostering innovation remain pivotal. This promising growth trajectory underscores the vital importance of animal models in driving scientific progress and enhancing the development of new therapies and treatments.

Key Takeaways from the USA Animal Model Market Study Report:

• Back in the year 2017, the demand for animal models in the United States, in terms of value, was nearly 818.7 million.
• Over the next ten years, the animal model market in the United States is projected to witness an absolute growth of USD 540.6 million.
• Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
• Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around USD 352.5 million in 2022, which was figured out to be 37.21% of the market.

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Landscape for the USA Animal Model Market Players:

Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of animal models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.

Recent Developments by the Animal Model Industries based in the USA:

• The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
• Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.

Key Companies Profiled:

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation).
• Harbour Biomed
• Sinclair BioResources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

Key Segments Covered by USA Animal Model Industry Survey Report:

By Species:

• Mice
• Rats
• Fish
• Birds
• Cattles
• Pigs
• Amphibians
• Guinea Pigs
• Dogs
• Cats
• Rabbits
• Monkeys
• Sheep
• Hamsters
• Other Animals

By Technology:

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Microinjection
• Nuclear Transfer
• Other Technologies

By Application:

• Research & Development
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD or NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Research and Developments
• Production and Quality Control
• Academics
• Preclinical Applications
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD/NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Preclinical Applications
• Other Applications

By Use:

• Human
• Veterinary

By End-user Verticals:

• Companies
  • Pharmaceutical
  • Biotechnology
  • Cosmetics
  • Other Companies
• Organizations
  • Government
  • Non-government
• Academic and Research Institutes
• Contract Research Organizations (CRO)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube